Filing Details

Accession Number:
0001189724-16-000015
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-03-31 19:03:33
Reporting Period:
2016-03-31
Filing Date:
2016-03-31
Accepted Time:
2016-03-31 19:03:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
883984 Icu Medical Inc ICUI Surgical & Medical Instruments & Apparatus (3841) 330022692
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1375852 E Scott Lamb 951 Calle Amanecer
San Clemente CA 92673
Secretary, Treasurer, No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-03-31 15,000 $37.00 19,381 No 4 X Direct
Common Stock Disposition 2016-03-31 15,000 $105.00 4,381 No 4 S Direct
Common Stock Acquisiton 2016-03-31 15,000 $32.31 19,381 No 4 X Direct
Common Stock Disposition 2016-03-31 15,000 $105.00 4,381 No 4 S Direct
Common Stock Acquisiton 2016-03-31 14,026 $38.85 18,407 No 4 X Direct
Common Stock Disposition 2016-03-31 14,026 $105.00 4,381 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 X Direct
No 4 S Direct
No 4 X Direct
No 4 S Direct
No 4 X Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2016-03-31 15,000 $32.31 15,000 $32.31
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2016-03-31 15,000 $37.00 15,000 $37.00
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2016-03-31 14,026 $38.85 14,026 $38.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-02-04 No 4 X Direct
0 2020-07-21 No 4 X Direct
0 2019-07-22 No 4 X Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2015.
  2. Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.
  3. Transaction is the exercise of a derivative security; see Column 2.